Return
Mechanisms of synergy of carboplatin and an EphA2-targeted docetaxel antibody-directed nanotherapeutic
DOI:10.1158/1538-7445.AM2017-3096.png)
Abstract
En
Journal
IF:
16.6
Papers:
10.9W
Citations:
11.9W
Organization
No organization information available

